Structural basis for recognition of cellular and viral ligands by NK cell receptors

Frontiers in Immunology

Volumn 5, Issue MAR, 2014, Pages

  Li, Yili ^a,b   Mariuzza, Roy A ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b Bldg 142   (United States)

Author keywords

KIR; Ly49; MHC; NK receptor; NKG2; Structure; Virus

Indexed keywords

B7 H6 PROTEIN; C TYPE LECTIN RECEPTOR; CD8 ANTIGEN; CD94 ANTIGEN; HLA A ANTIGEN; HLA A2 ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; KERATINOCYTE ASSOCIATED C TYPE LECTIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL LECTIN LIKE RECEPTOR G1 CADHERIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MIXED LINEAGE LEUKEMIA 5 PROTEIN; NATURAL CYTOTOXICITY RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; NKP65 PROTEIN; NKP80 PROTEIN; PEPTIDES AND PROTEINS; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN; VIRUS HEMAGGLUTININ;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIVIRAL ACTIVITY; CELL ACTIVATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DNA DAMAGE; DNA POLYMORPHISM; HUMAN; IMMUNOSURVEILLANCE; NONHUMAN; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; SEQUENCE ANALYSIS; VIRUS REPLICATION;

EID: 84897953300     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00123     Document Type: Review

References (185)

1. Di Santo JP. Natural killer cells: diversity in search of a niche. Nat Immunol (2008) 9:473-5. doi: 10.1038/ni.f.201
2. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol (2008) 9:503-10. doi:10.1038/ni1582
3. Caliguiri MA. Human natural killer cells. Blood (2008) 112:461-9. doi:10.1182/blood-2007-09-077438
4. Bryceson YT, Chiang SC, Darmanin S, Fauriat C, Schlums H, Theorell J, et al. Molecular mechanisms of natural killer cell activation. J Innate Immun (2011) 3:216-26. doi:10.1159/000325265
5. Vivier E, Raulet DH, Moretta A, Caliguiri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science (2011) 331:44-9. doi:10.1126/science.1198687
6. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol (2008) 9:495-502. doi:10.1038/ni1581
7. Long EO, Sik KH, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 31:227-58. doi:10.1146/annurev-immunol-020711-075005
8. Kelley J, Walter L, Trowsdale J. Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet (2005) 1:129-39. doi:10.1371/journal.pgen.0010027
9. Yokoyama WM, Plougastel BFM. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol (2003) 3:304-16. doi:10.1038/nri1055
10. Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH. Structure and function of natural killer cell receptors: multiple molecular solutions to self, non-self discrimination. Annu Rev Immunol (2002) 20:853-85. doi:10.1146/annurev.immunol.20.100301.064812
11. Deng L, Mariuzza RA. Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors. Semin Immunol (2006) 18:159-66. doi:10.1016/j.smim.2006.03.004
12. Joyce MG, Sun PD. The structural basis of ligand recognition by natural killer cell receptors. J Biomed Biotechnol (2011) 2011:203628. doi:10.1155/2011/203628
13. Finton KA, Strong RK. Structural insights into activation of antiviral NK cell responses. Immunol Rev (2012) 250:239-57. doi:10.1111/j.1600-065X.2012.01168.x
14. Mistry AR, O'Callaghan CA. Regulation of ligands for the activating receptor NKG2D. Immunology (2007) 121:439-47. doi:10.1111/j.1365-2567.2007.02652.x
15. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 296:1323-6. doi:10.1126/science.1070884
16. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A (2002) 99:8826-31. doi:10.1073/pnas.092258599
17. Derosiers M-P, Kielczewska A, Loredi-Osti J-C, Adam SG, Makrigiannis AP, Lemiex S, et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet (2005) 37:593-9. doi:10.1038/ng1564
18. Lanier LL, Ruitenberg JJ, Phillips JH. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol (1988) 141:3478-85.
19. Moretta A, Poggi A, Pende D, Tripodi G, Orengo AM, Pella N, et al. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α/β. J Exp Med (1991) 174:1393-8. doi:10.1084/jem.174.6.1393
20. Plougastel BF, Yokoyama WM. Extending missing self? Functional interactions between lectin-like NKrp1 receptors on NK cells with lectin-like ligands. Curr Top Microbiol Immunol (2006) 298:77-89.
21. Bartel Y, Bauer B, Steinle A. Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complex. Front Immunol (2013) 4:362. doi:10.3389/fimmu.2013.00362
22. Veillette A, Dong Z, Latour S. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes. Immunity (2007) 27:698-710. doi:10.1016/j.immuni.2007.11.005
23. Ma CS, Nichols KE, Tangye SG. Regulation of cellular and humoral responses by the SLAM and SAP families of molecules. Annu Rev Immunol (2007) 25:337-79. doi:10.1146/annurev.immunol.25.022106.141651
24. Chlewicki LK, Velikovsky CA, Balakrishnan V, Mariuzza RA, Kumar V. Molecular basis of the dual function of 2B4 (CD244). J Immunol (2008) 180:8159-67.
25. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity (1996) 4:573-81. doi:10.1016/S1074-7613(00)70060-4
26. Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med (1999) 190:1505-16. doi:10.1084/jem.190.10.1505
27. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med (1999) 189:787-96. doi:10.1084/jem.189.5.787
28. Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, et al. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med (1997) 186:1129-36. doi:10.1084/jem.186.7.1129
29. Spreu J, Kuttruff S, Stejfova V, Dennehy KM, Schittek B, Steinle A. Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes. Proc Natl Acad Sci U S A (2010) 107:5100-5. doi:10.1073/pnas.0913108107
30. Vitale M, Falco M, Castriconi R, Parolini S, Zambello R, Semenzato G, et al. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol (2001) 31:233-42. doi:10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.3.CO;2-W
31. Welte S, Kuttruff S, Waldhauer I, Steinle A. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol (2006) 7:1334-42. doi:10.1038/ni1402
32. Ito M, Maruyama T, Saito N, Koganei S, Yamamoto K, Matsumoto N. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med (2006) 203:289-95. doi:10.1084/jem.20051986
33. Gründemann C, Bauer M, Schweier O, von Oppen N, Lässing U, Saudan P, et al. Cutting edge: Identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1 (KLRG1). J Immunol (2006) 176:1311-5.
34. Lebbink RJ, de Ruiter T, Adelmeijer J, Brenkman AB, van Helvoort JM, Koch M, et al. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med (2006) 203:1419-25. doi:10.1084/jem.20052554
35. Fan QR, Mosyak L, Winter CC, Wagtmann N, Long EO, Wiley DC. Structure of the inhibitory receptor for human natural killer cells resembles hematopoietic receptors. Nature (1997) 389:96-100. doi:10.1038/38028
36. Snyder GA, Brooks AG, Sun PD. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc Natl Acad Sci U S A (1999) 96:3864-9. doi:10.1073/pnas.96.7.3864
37. Maenaka K, Juji T, Stuart DI, Jones EY. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. Structure (1999) 7:391-8. doi:10.1016/S0969-2126(99)80052-5
38. Saulquin X, Gastinel LN, Vivier E. Crystal structure of the human natural killer cell activator receptor KIR2DS2 (CD158j). J Exp Med (2003) 197:933-8. doi:10.1084/jem.20021624
39. Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM, et al. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med (2009) 206:2557-72. doi:10.1084/jem.20091010
40. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature (2000) 405:537-43. doi:10.1038/35014520
41. Fan QR, Long EO, Wiley DC. Crystal structure of the human natural killer inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol (2001) 2:452-60.
42. Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, Beddoe T, et al. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature (2011) 479:401-5. doi:10.1038/nature10517
43. de Vos AM, Ultsch M, Kossiakoff AA. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science (1992) 255:306-12. doi:10.1126/science.1549776
44. Somers W, Ultsch M, De Vos AM, Kossiakoff AA. The X-ray structure of a growth hormone-prolactin receptor complex. Nature (1994) 372:478-81. doi:10.1038/372478a0
45. Rajakopalan S, Long EO. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med (1997) 185:1523-8. doi:10.1084/jem.185.8.1523
46. Zappacosta F, Borrego F, Brooks AG, Parker KC, Coligan JE. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci U S A (1997) 94:6313-8. doi:10.1073/pnas.94.12.6313
47. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature (2011) 476:96-100. doi:10.1038/nature10237
48. Yin Y, Li Y, Mariuzza RA. Structural basis for self-recognition by autoimmune T-cell receptors. Immunol Rev (2012) 250:32-48. doi:10.1111/imr.12002
49. Norman PJ, Abi-Rached L, Gendzekhadze K, Korbel D, Gleimer M, Rowley D, et al. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet (2007) 39:1092-9. doi:10.1038/ng2111
50. Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens (2004) 64:215-25. doi:10.1111/j.0001-2815.2004.00290.x
51. Chapman TL, Haikema AP, Bjorkmann PJ. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral MHC homolog UL18. Immunity (1999) 11:603-11. doi:10.1016/S1074-7613(00)80135-1
52. Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, et al. Human inhibitory receptors ILT2 and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A (2003) 100:8856-61. doi:10.1073/pnas.1431057100
53. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity (1997) 7:273-82. doi:10.1016/S1074-7613(00)80529-4
54. Chapman TL, Heikema AP, West AP Jr., Bjorkman PJ. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT-2). Immunity (2000) 13:727-36. doi:10.1016/S1074-7613(00)00071-6
55. Willcox BE, Thomas LM, Bjorkman PJ. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol (2003) 4:913-9. doi:10.1038/ni961
56. Yang Z, Bjorkman PJ. Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor. Proc Natl Acad Sci U S A (2008) 105:10095-100. doi:10.1073/pnas.0804551105
57. Willcox BE, Thomas LM, Chapman TL, Heikema AP, West AP Jr., Bjorkman PJ. Crystal structure of LIR-2 (ILT4) at 1.8 Å: differences from LIR-1 (ILT2) in regions implicated in the binding of the human cytomegalovirus class I MHC homolog UL18. BMC Struct Biol (2002) 2:6. doi:10.1186/1472-6807-2-6
58. Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, Kurimoto E, et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A (2006) 103:16412-7. doi:10.1073/pnas.0605228103
59. Masuda A, Nakamura A, Maeda T, Sakamoto Y, Takai T. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J Exp Med (2007) 204:907-20. doi:10.1084/jem.20060631
60. Held W, Mariuzza RA. Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat Rev Immunol (2008) 8:269-78. doi:10.1038/nri2278
61. Farrell H, Degli-Esposti M, Densley E, Cretney E, Smyth M, Davis-Poynter N. Cytomegalovirus MHC class I homologues and natural killer cells: an overview. Microbes Infect (2000) 2:521-32. doi:10.1016/S1286-4579(00)00315-4
62. Basta S, Bennink JR. A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways. Viral Immunol (2003) 16:231-42.
63. Revilleza MJ, Wang R, Mans J, Hong M, Natarajan K, Margulies DH. How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance. J Biomed Biotechnol (2011) 2011:724607. doi:10.1155/2011/724607
64. Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature (1988) 331:269-72. doi:10.1038/331269a0
65. Wagner CS, Ljunggren HG, Achour A. Immune modulation by the human cytomegalovirus-encoded molecule UL18, a mystery yet to be solved. J Immunol (2008) 180:19-24.
66. Fahnestock ML, Johnson JL, Feldman RM, Neveu JM, Lane WS, Bjorkman PJ. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity (1995) 3:583-90. doi:10.1016/1074-7613(95)90129-9
67. Wagner CS, Rölle A, Cosman D, Ljunggren HG, Berndt KD, Achour A. Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1. J Mol Biol (2007) 373:695-705. doi:10.1016/j.jmb.2007.08.020
68. Julien J-P, Lee PS, Wilson IA. Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA. Immunol Rev (2012) 250:180-98. doi:10.1111/imr.12005
69. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 19:197-223. doi:10.1146/annurev.immunol.19.1.197
70. Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A. Surface NK receptors and their ligands on tumor cells. Semin Immunol (2006) 18:151-8. doi:10.1016/j.smim.2006.03.002
71. Bryceson YT, Long EO. Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol (2008) 20:344-52. doi:10.1016/j.coi.2008.03.005
72. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature (2001) 409:1055-60. doi:10.1038/35059110
73. De Maria A, Fogli M, Mazza S, Basso M, Picciotto A, Costa P, et al. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol (2007) 37:445-55. doi:10.1002/eji.200635989
74. Hershkovitz O, Rosental B, Rosenberg LA, Navarro-Sanchez ME, Jivov S, Zilka A, et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol (2009) 183:2610-21. doi:10.4049/jimmunol.0802806
75. Fuller CL, Ruthel G, Warfield KL, Swenson DL, Bosio CM, Aman MJ, et al. NKp30-dependent cytolysis of filovirus-infected human dendritic cells. Cell Microbiol (2007) 9:962-76. doi:10.1111/j.1462-5822.2006.00844.x
76. Ho JW, Hershkovitz O, Peiris M, Zilka A, Bar-Ilan A, Nal B, et al. H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J Virol (2008) 82:2028-32. doi:10.1128/JVI.02065-07
77. Jarahian M, Fiedler M, Cohnen A, Djandji D, Hämmerling GJ, Gati C, et al. Modulation of NKp30-and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog (2011) 7:e1002195. doi:10.1371/journal.ppat.1002195
78. Hecht ML, Rosental B, Horlacher T, Hershkovitz O, De Paz JL, Noti C, et al. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J Proteome Res (2009) 8:712-20. doi:10.1021/pr800747c
79. Baychelier F, Sennepin A, Ermonval M, Dorgham K, Debré P, Vieillard V. Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. Blood (2013) 122:2935-42. doi:10.1182/blood-2013-03-489054
80. Pogge von Strandmann E, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP, et al. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity (2007) 27:965-74. doi:10.1016/j.immuni.2007.10.010
81. Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med (2009) 206:1495-503. doi:10.1084/jem.20090681
82. Sasaki T, Gan EC, Wakeham A, Kornbluth S, Mak TW, Okada H. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev (2007) 21:848-61. doi:10.1101/gad.1534107
83. Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol (2008) 8:467-77. doi:10.1038/nri2326
84. Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol (2005) 6:515-23. doi:10.1038/ni1190
85. Li SS, Kyei SK, Timm-McCann M, Ogbomo H, Jones GJ, Shi M, et al. The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients. Cell Host Microbe (2013) 14:387-97. doi:10.1016/j.chom.2013.09.007
86. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol (2003) 3:781-90. doi:10.1038/nri1199
87. Soriani A, Zingoni A, Cereboni C, Iannitto ML, Ricciardi MR, DiGialleonardo V, et al. ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK cell susceptibility and is associated with a senescent phenotype. Blood (2009) 113:3503-11. doi:10.1182/blood-2008-08-173914
88. Cantoni C, Ponassi M, Biossoni R, Conte R, Spallarossa A, Moretta A, et al. The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity. Structure (2003) 11:725-34. doi:10.1016/S0969-2126(03)00095-9
89. Foster CE, Colonna M, Sun PD. Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors. J Biol Chem (2003) 278:46081-6. doi:10.1074/jbc.M308491200
90. Joyce MG, Tran P, Zhuravleva MA, Jaw J, Colonna M, Sun PD. Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site. Proc Natl Acad Sci U S A (2011) 108:6223-8. doi:10.1073/pnas.1100622108
91. Li Y, Wang Q, Mariuzza RA. Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6. J Exp Med (2011) 208:703-14. doi:10.1084/jem.20102548
92. Lin DY, Tanaka Y, Iwasaki M, Gittis AG, Su H-P, Mikami B, et al. The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc Natl Acad Sci U S A (2008) 105:3011-6. doi:10.1073/pnas.0712278105
93. Lazar-Molnar E, Yan Q, Cao E, Ramagopal U, Nathenson SG, Almo SC. Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2. Proc Natl Acad Sci U S A (2008) 105:10483-8. doi:10.1073/pnas.0804453105
94. Stamper CC, Zhang Y, Tobin JF, Erbe DV, Ikemizu S, Davis SJ, et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature (2001) 410:608-11. doi:10.1038/35069118
95. Schwartz J-CD, Zhang X, Federov AA, Nathenson SG, Almo SC. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature (2001) 410:604-7. doi:10.1038/35069112
96. Plougastel BFM, Yokoyama WM. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol (2003) 3:304-16. doi:10.1038/nri1055
97. Anderson SK, Ortaldo JR, McVicar DW. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol Rev (2001) 181:79-89. doi:10.1034/j.1600-065X.2001.1810106.x
98. Lanier LL. NK cell recognition. Annu Rev Immunol (2005) 23:225-74. doi:10.1146/annurev.immunol.23.021704.115526
99. McFall E, Tu MM, Al-Khattabi N, Tai L-H, St-Laurent AS, Tzankova V, et al. Optimized tetramer analysis reveals Ly49 promiscuity for MHC ligands. J Immunol (2013) 191:5722-9. doi:10.4049/jimmunol.1300726
100. Franksson L, Sundbäck J, Achour A, Bernlind J, Glas R, Kärre K. Peptide dependency and selectivity of the NK inhibitory receptor Ly-49C. Eur J Immunol (1999) 29:2748-58. doi:10.1002/(SICI)1521-4141(199909)29:09<2748::AID-IMMU2748>3.3.CO;2-3
101. Hanke T, Takizawa H, McMahon CW, Busch DH, Pamer EG, Miller JD, et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity (1999) 11:67-77. doi:10.1016/S1074-7613(00)80082-5
102. Tormo J, Natarajan K, Margulies DH, Mariuzza RA. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature (1999) 402:623-31. doi:10.1038/45170
103. Dam J, Guan R, Natarajan K, Dimasi N, Chlewicki LK, Kranz DM, et al. Variable MHC class I engagement by Ly49 NK receptors revealed by the crystal structure of Ly49C bound to H-2Kb. Nat Immunol (2003) 4:1213-22. doi:10.1038/ni1006
104. Deng L, Cho S, Malchiodi EL, Kerzic MC, Dam J, Mariuzza RA. Molecular architecture of the major histocompatibility complex class I-binding site of Ly49 natural killer cell receptors. J Biol Chem (2008) 283:16840-9. doi:10.1074/jbc.M801526200
105. Dimasi N, Sawicki MW, Reineck LA, Li Y, Natarajan K, Margulies DH, et al. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family. J Mol Biol (2002) 320:573-85. doi:10.1016/S0022-2836(02)00498-9
106. Back J, Malchiodi EL, Cho S, Scarpellino L, Schneider P, Kerzic MC, et al. Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. Immunity (2009) 31:598-608. doi:10.1016/j.immuni.2009.07.007
107. Berry R, Ng N, Saunders PM, Vivian JP, Lin J, Deuss FA, et al. Targeting of a natural killer cell receptor family by a viral immunoevasin. Nat Immunol (2013) 14:699-705. doi:10.1038/ni.2605
108. Dam J, Baber J, Grishaev A, Malchiodi EL, Schuck P, Bax A, et al. Variable dimerization of the Ly49A natural killer cell receptor results in differential engagement of its MHC class I ligand. J Mol Biol (2006) 362:102-13. doi:10.1016/j.jmb.2006.07.005
109. Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen MB, Munks MW, et al. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med (2009) 206:515-23. doi:10.1084/jem.20080954
110. Kavanagh DG, Gold MC, Wagner M, Koszinowski UH, Hill AB. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J Exp Med (2001) 194:967-78. doi:10.1084/jem.194.7.967
111. Held W, Mariuzza RA. Cis-trans interactions of cell surface receptors: biological roles and structural basis. Cell Mol Life Sci (2011) 68:3469-78. doi:10.1007/s00018-011-0798-z
112. Doucey M-A, Scarpellino L, Zimmer J, Guillaume P, Luescher IF, Bron C, et al. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat Immunol (2004) 5:328-36. doi:10.1038/ni1043
113. d cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact. Proc Natl Acad Sci U S A (2007) 104:3978-83. doi:10.1073/pnas.0607418104
114. Razi N, Varki A. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci U S A (1998) 95:7469-74. doi:10.1073/pnas.95.13.7469
115. Collins BE, Blixt O, Bovin NV, Danzer CP, Chui D, Marth JD, et al. Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22. Glycobiology (2002) 12:563-71. doi:10.1093/glycob/cwf067
116. Poe JC, Fujimoto Y, Hasegawa M, Haas KM, Miller AS, Sanford IG, et al. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat Immunol (2004) 5:1078-87. doi:10.1038/ni1121
117. Collins BE, Blixt O, DeSieno AR, Bovin N, Marth JD, Paulson JC. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc Natl Acad Sci U S A (2004) 101:6104-9. doi:10.1073/pnas.0400851101
118. Cheung TC, Oborne LM, Steinberg MW, Macauley MG, Fukuyama S, Sanjo H, et al. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment. J Immunol (2009) 183:7286-96. doi:10.4049/jimmunol.0902490
119. Haklai-Topper L, Mlechkovich G, Savariego D, Gokhman I, Yaron A. Cis interaction between semaphorin-6A and plexin-A4 modulates the repulsive response to Sema6A. EMBO J (2010) 29:2635-45. doi:10.1038/emboj.2010.147
120. Cordle J, Johnson S, Tay JZ, Roversi P, Wilkin MB, de Madrid BH, et al. A conserved face of the jagged/serrate DSL domain is involved in notch trans-activation and cis-inhibition. Nat Struct Mol Biol (2008) 15:849-57. doi:10.1038/nsmb.1457
121. Sprinzak D, Lakhanpal A, Lebon L, Santat LA, Fontes ME, Anderson GA, et al. Cis-interactions between notch and Delta generate mutually exclusive signalling states. Nature (2010) 465:86-90. doi:10.1038/nature08959
122. Chalifour A, Scarpellino L, Back J, Brodin P, Devevre E, Gros F, et al. A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for NK cell education. Immunity (2009) 30:337-47. doi:10.1016/j.immuni.2008.12.019
123. Romasanta PN, Curto LM, Urtasun N, Sarratea MB, Chiappini S, Miranda MV, et al. A positive cooperativity binding model between Ly49 natural killer cell receptors and the viral immunoevasin m157: kinetic and thermodynamic studies. J Biol Chem (2014) 289:5083-96. doi:10.1074/jbc.M113.532929
124. Meijers R, Puettmann-Holgado R, Skiniotis G, Liu JH, Walz T, Wang JH, et al. Structural basis of Dscam isoform specificity. Nature (2007) 449:487-91. doi:10.1038/nature06147
125. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol (2008) 8:259-68. doi:10.1038/nri2276
126. Daniels KA, Devora G, Lai WC, O'Donnell CL, Bennett M, Walsh RM. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med (2001) 194:29-44. doi:10.1084/jem.194.1.29
127. Lee S-H, Girard S, Macina D, Busa M, Zafer A, Belouchi A, et al. Susceptibility to mouse cytomegalovirus is associated with depletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet (2001) 28:42-5. doi:10.1038/88247
128. Lee S-H, Zafer A, de Repentigny Y, Kothary R, Tremblay ML, Gros P, et al. Transgenic expression of the activating natural killer cell receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med (2003) 197:515-26. doi:10.1084/jem.20021713
129. Voigt V, Forbes CA, Tonkin JN, Degli-Esposti MA, Smith HR, Yokoyama WM, et al. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A (2003) 100:13483-8. doi:10.1073/pnas.2233572100
130. French AR, Pingel JT, Wagner M, Bubic I, Yang L, Kim S, et al. Escape of mutant double-stranded DNA virus from innate immune control. Immunity (2004) 20:747-56. doi:10.1016/j.immuni.2004.05.006
131. Corbett AJ, Coudert JD, Forbes CA, Scalzo AA. Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation. J Immunol (2011) 186:1713-22. doi:10.4049/jimmunol.1003308
132. Adams EJ, Juo ZS, Venook RT, Boulanger MJ, Arase H, Lanier LL, et al. Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc Natl Acad Sci U S A (2007) 104:10128-33. doi:10.1073/pnas.0703735104
133. Vivier E, Tomasello E, Paul P. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr Opin Immunol (2002) 14:306-11. doi:10.1016/S0952-7915(02)00337-0
134. Radaev S, Rostro B, Brooks AG, Colonna M, Sun P. Conformational plasticity revealed by the co-crystal structure of the activating NK receptor NKG2D and its MHC-like ligand ULBP. Immunity (2001) 15:1039-49. doi:10.1016/S1074-7613(01)00241-2
135. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science (1998) 279:1737-40. doi:10.1126/science.279.5357.1737
136. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc Natl Acad Sci U S A (1999) 96:6879-84. doi:10.1073/pnas.96.12.6879
137. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity (2000) 12:721-7. doi:10.1016/S1074-7613(00)80222-8
138. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol (2000) 1:119-26. doi:10.1038/77793
139. Wang R, Natarajan K, Revilleza MJ, Boyd LF, Zhi L, Zhao H, et al. Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1β reveals a paradigm for MHC/MHC interaction in immune evasion. Proc Natl Acad Sci U S A (2012) 109:E3578-87. doi:10.1073/pnas.1214088109
140. Müller S, Zocher G, Steinle A, Stehle T. Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands. PLoS Pathog (2010) 6:e1000723. doi:10.1371/journal.ppat.1000723
141. McFarland BJ, Kortemme T, Yu SF, Baker D, Strong RK. Symmetry recognizing asymmetry: analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands. Structure (2003) 11:411-22. doi:10.1016/S0969-2126(03)00047-9
142. Wolan DW, Teyton L, Rudolph MG, Villmow B, Bauer S, Busch DH, et al. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 Å. Nat Immunol (2001) 2:248-54. doi:10.1038/85311
143. Li P, Morris DL, Willcox BE, Steinle A, Spies T, Strong RK. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol (2001) 2:443-51.
144. Li P, McDermott G, Strong RK. Crystal structure of RAE-1β and its complex with the activating immunoreceptor NKG2D. Immunity (2002) 16:77-86. doi:10.1016/S1074-7613(02)00258-3
145. Li P, Willie ST, Bauer S, Morris DL, Spies T, Strong RK. Crystal structure of the MHC class I homolog MICA, a γδ T cell ligand. Immunity (1999) 10:577-84. doi:10.1016/S1074-7613(00)80057-6
146. McFarland BJ, Strong RK. Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation. Immunity (2003) 19:803-12. doi:10.1016/S1074-7613(03)00320-0
147. Lodoen M, Ogasawara K, Hamerman JA, Arase A, Houchins JP, Mocarski ES, et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med (2003) 197:1245-53. doi:10.1084/jem.20021973
148. Lodoen MB, Abenes G, Umamoto S, Houchins JP, Liu F, Lanier LL. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med (2004) 200:1075-81. doi:10.1084/jem.20040583
149. Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, Lenac T, et al. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by mouse cytomegalovirus gene m145. J Exp Med (2005) 201:211-20. doi:10.1084/jem.20041617
150. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med (1998) 187:813-8. doi:10.1084/jem.187.5.813
151. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 391:795-9.
152. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, López-Botet M, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A (1998) 95:5199-204. doi:10.1073/pnas.95.9.5199
153. Sullivan LC, Clements CS, Beddoe T, Johnson D, Hoare HL, Lin J, et al. The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition. J Exp Med (2008) 205:725-35.
154. Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D, Huyton T, et al. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med (2008) 205:725-35. doi:10.1084/jem.20072525
155. Kaiser BK, Pizarro JC, Kerns J, Strong RK. Structural basis for NKG2A/CD94 recognition of HLA-E. Proc Natl Acad Sci U S A (2008) 105:6696-701. doi:10.1073/pnas.0802736105
156. Guthman MD, Tal M, Pecht I. A secretion inhibitory signal transduction molecule on mast cells is another C-type lectin. Proc Natl Acad Sci U S A (1995) 92:9397-401. doi:10.1073/pnas.92.20.9397
157. Hanke T, Corral L, Vance RE, Raulet DH. 2F1 antigen, the mouse homolog of the rat "mast cell function-associated antigen", is a lectin-like type II transmembrane receptor expressed by natural killer cells. Eur J Immunol (1998) 28:4409-17. doi:10.1002/(SICI)1521-4141(199812)28:12<4409::AID-IMMU4409>3.0.CO;2-3
158. Voehringer D, Blaser P, Brawand P, Raulet DH, Hanke T, Pircher H. Viral infections induce abundant numbers of senescent CD8 T cells. J Immunol (2001) 167:4838-43.
159. Robbins SH, Terrizzi SC, Sydora BC, Mikayama T, Brossay L. Differential regulation of killer cell lectin-like receptor G1 expression on T cells. J Immunol (2003) 170:5876-85.
160. Thimme R, Appay V, Koschella M, Panther E, Roth E, Hislop AD, et al. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J Virol (2005) 79:12112-6. doi:10.1128/JVI.79.18.12112-12116.2005
161. Ibegbu CC, Xu YX, Harris W, Maggio D, Miller JD, Koutis AP. Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. J Immunol (2005) 174:6088-94.
162. Tessmer MS, Fugere C, Stevenaert F, Naidenko OV, Chong HJ, Leclercq G, et al. KLRG1 binds cadherins and preferentially associates with SHIP-1. Int Immunol (2007) 4:391-400. doi:10.1093/intimm/dxm004
163. Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol (2005) 6:622-34. doi:10.1038/nrm1699
164. Colonna M. Cytolytic responses: cadherins put out the fire. J Exp Med (2006) 203:261-4. doi:10.1084/jem.20052559
165. Schwartzkopff S, Gründemann C, Schweier O, Rosshart S, Karjalainen KE, Becker K-F, et al. Tumor-associated E-cadherin mutations affect binding to the killer cell lectin-like receptor G1 in humans. J Immunol (2007) 179:1022-9.
166. Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene (2008) 24:6920-9. doi:10.1038/onc.2008.343
167. Li Y, Hofmann M, Wang Q, Teng L, Chlewicki LK, Pircher H, et al. Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition. Immunity (2009) 31:35-46. doi:10.1016/j.immuni.2009.04.019
168. Lo Conte LL, Chothia C, Janin J. The atomic structure of protein-protein recognition sites. J Mol Biol (1999) 285:2177-98. doi:10.1006/jmbi.1998.2439
169. Corral L, Hanke T, Vance RE, Cado D, Raulet DH. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur J Immunol (2000) 30:920-30. doi:10.1002/1521-4141(200003)30:3<920::AID-IMMU920>3.3.CO;2-G
170. Rosshart S, Hofmann M, Schweier O, Pfaff A-K, Yoshimoto K, Takeuchi T, et al. Interaction of KLRG1 with E-cadherin: new functional and structural insights. Eur J Immunol (2008) 38:3354-64. doi:10.1002/eji.200838690
171. Hao L, Klein J, Nei M. Heterogeneous but conserved natural killer receptor gene complexes in four major orders of mammals. Proc Natl Acad Sci U S A (2006) 103:3192-7. doi:10.1073/pnas.0511280103
172. Iizuka K, Naidenko OV, Plougastel BF, Fremont DH, Yokoyama WM. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol (2003) 4:801-7. doi:10.1038/ni954
173. Carlyle JR, Jamieson AM, Gasser S, Clingan CS, Arase H, Raulet DH. Missing self recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc Natl Acad Sci U S A (2004) 101:3527-32. doi:10.1073/pnas.0308304101
174. Fine JH, Chen P, Mesci A, Allan DS, Gasser S, Raulet DH, et al. Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing self recognition. Cancer Res (2010) 70:7102-13. doi:10.1158/0008-5472.CAN-10-1316
175. Aldemir H, Prod'homme V, Dumaurier MJ, Retiere C, Poupon G, Cazareth J, et al. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol (2005) 175:7791-5.
176. Rosen DB, Bettadapura J, Alsharifi M, Mathew PA, Warren HS, Lanier LL. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol (2005) 175:7796-9.
177. Rosen DB, Cao W, Avery DT, Tangye SG, Liu YJ, Houchins JP, et al. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. J Immunol (2008) 180:6508-17.
178. Germain C, Meier A, Jensen T, Knapnougel P, Poupon G, Lazzari A, et al. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses. J Biol Chem (2011) 286:37964-75. doi:10.1074/jbc.M111.285312
179. Klimosch SN, Bartel Y, Wiemann S, Steinle A. Genetically coupled receptor-ligand pair NKp80-AICL enables autonomous control of human NK cell responses. Blood (2013) 122:2380-99. doi:10.1182/blood-2013-01-479790
180. Spreu J, Kienle EC, Schrage B, Steinle A. CLEC2A: a novel, alternatively spliced and skin-associated member of the NKC-encoded AICL-CD69-LLT1 family. Immunogenetics (2007) 59:903-12. doi:10.1007/s00251-007-0263-1
181. Vogler I, Steinle A. Vis-à-vis in the NKC: genetically linked natural killer cell receptor/ligand pairs in the natural killer gene complex (NKC). J Innate Immun (2011) 3:227-35. doi:10.1159/000324112
182. Li Y, Wang Q, Chen S, Brown PH, Mariuzza RA. Structure of NKp65 bound to its keratinocyte ligand reveals basis for genetically linked recognition in natural killer gene complex. Proc Natl Acad Sci U S A (2013) 110:11505-10. doi:10.1073/pnas.1303300110
183. Davis SJ, Ikemizu S, Evans EJ, Fugger L, Bakker TR, van der Merwe PA. The nature of molecular recognition by T cells. Nat Immunol (2003) 4:217-24. doi:10.1038/ni0303-217
184. Kamishikiryo J, Fukuhara H, Okabe Y, Kuroki K, Maenaka K. Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1). J Biol Chem (2011) 286:23823-30. doi:10.1074/jbc.M110.214254
185. Call ME, Wucherpfennig K, Chou JJ. The structural basis for intramembrane assembly of an activating immunoreceptor complex. Nat Immunol (2010) 11:1023-9. doi:10.1038/ni.1943